Home

LLP Abingworth

CIK 1397144 · last filed 2024-02-12

LLP Abingworth is a corporate insider who has filed 37 SEC Form 4 insider transactions across 12 companies since 2011. The most recent filing shows the insider bought $24.6M of JSPRW on Feb 12, 2024. Across all open-market trades the lifetime net is −$185.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $146.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$146.50M

Companies

12

Total Filings

37

Lifetime Open-Market Net

-$185.72M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
JSPRW 10%+ Owner 1,066,189 $0.01 $12.9K $24.61M 2 2024-02-12
VERA 10%+ Owner 2,966,875 $33.32 $98.86M $6.49M 2 2022-08-19
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 1,201,507 $53.01 $63.69M $5.50M 2 2022-03-31
Sierra Oncology, Inc. (SRRA) Delisted 10%+ Owner 1,164,127 $54.99 $64.02M $4.05M 1 2022-02-01
eFFECTOR Therapeutics, Inc. (EFTRW) Delisted 10%+ Owner — $0.00 — $0 1 2021-12-17
PSNL 10%+ Owner 3,753,340 $11.88 $44.59M -$38.49M 6 2020-10-21
PCVX 10%+ Owner — $54.60 — $0 2 2020-06-16
PRTO 10%+ Owner 53,613 $27.04 $1.45M $0 6 2019-11-14
SOLENO THERAPEUTICS INC (SLNOW) Delisted 10%+ Owner 6,969,272 — — $2.76M 1 2019-10-29
Sientra, Inc. (SIEN) Delisted 10%+ Owner 248,049 $0.17 $43.2K $11.23M 2 2018-05-09
CHIASMA, INC (CHMA) Delisted 10%+ Owner 2,080,595 $3.76 $7.82M $0 2 2016-03-09
AMRN 10%+ Owner 114,058 $13.95 $1.59M -$201.86M 10 2012-04-26

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-12 JSPRW Buy (P) +1,900,000 $24.61M EDGAR
2022-08-19 VERA Mixed — -$918.5K EDGAR
2022-03-31 SOLENO THERAPEUTICS INC (SLNO) Delisted Mixed +7,720,000 $0 EDGAR
2022-03-23 JSPRW Grant (A) — $0 EDGAR
2022-02-01 Sierra Oncology, Inc. (SRRA) Delisted Mixed +437,471 $7.84M EDGAR
2021-12-17 eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Grant (A) — $0 EDGAR
2021-05-18 VERA Mixed +2,960,231 $8.50M EDGAR
2020-10-21 PSNL Sell (S) −130,486 -$3.61M EDGAR
2020-10-20 PSNL Sell (S) −290,641 -$7.99M EDGAR
2020-10-16 PSNL Sell (S) −85,625 -$2.32M EDGAR
Showing 1–10 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.